当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2016年第10期
编号:12856570
猪苓汤与小蓟饮子治疗湿热型IgA肾病的临床效果(4)
http://www.100md.com 2016年4月5日 《中国医药导报》 2016年第10期
     [16] 岑文新.常规疗法基础上加用六味地黄汤和猪苓汤治疗慢性肾小球肾炎43例[J].光明中医,2014,29(4):733-734.

    [17] Wang JY,Gao YB,Zhang N,et al. miR-21overexpression enhances TGF-betal-induced epithelial-to-mesenchymal transition by target srnad and aggravates renal damage in diabetic nephropathy [J]. Mol Cell Endocrinol,2014,392(1-2):163-172.

    [18] Mao Z,Xie G,Ong AC. Metabolic abnormalities in autosomal dominant polycustic kidney disease [J]. Nephrol Dial Transpl,2015,30(2):197-203.

    [19] Wang JY,Gao YB,Zhang N,et al. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy [J]. Am J Physiol Renal Physiol,2014,306(5):486-495.

    [20] Danger R,Pallier A,Giral M,et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationlly tolerant patients with a renal transplant [J]. JASN,2012,23(4):597-606.

    [21] Kriegel AJ,Fang Y,Liu Y,et al. MicroRNA-tatget pairs in human renal epithelial cells treated with transforming growth factor beta 1:a novel role of miR-382 [J]. Nucleic Acids Res,2010,38(22):8338-8347.

    [22] Anglicheau D,Sharma VK,Ding R,et al. MicroRNA expression profiles predictive of human renal allograft status [J]. P Natl Acad Sci USA,2009,106(13):5330-5335., 百拇医药(伍庆华 延丽萍)
上一页1 2 3 4